Seminars in Thrombosis and Hemostasis, Table of Contents Semin Thromb Hemost 2009; 35(6): 525-526DOI: 10.1055/s-0029-1240012 PREFACE© Thieme Medical PublishersAntithrombotic Management of Atrial FibrillationMarcel Levi1 1Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Recommend Article Abstract Buy Article(opens in new window) Full Text References REFERENCE 1 Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3, Suppl) 204S-233S 2 Hirsh J, Guyatt G, Albers G W, Schunemann H J. Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004; 126(3, Suppl) 172S-696S 3 Levi M, Hobbs R, Jacobson A K et al.. Improving oral anticoagulation management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost. 2009; 35(6) 527-542 4 Fitzmaurice D A, Hobbs F D. Anticoagulant management in patients with atrial fibrillation. Semin Thromb Hemost. 2009; 35(6) 543-547 5 Hylek E M. Antithrombotic prophylaxis in elderly patients with atrial fibrillation. Semin Thromb Hemost. 2009; 35(6) 548-553 6 Pisters R, de Vos C B, Nieuwlaat R, Crijns H JGM. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Semin Thromb Hemost. 2009; 35(6) 554-559 7 Levi M, Hovingh G K, Cannegieter S C, Vermeulen M, Büller H R, Rosendaal F R. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood. 2008; 111(9) 4471-4476 8 Levi M, de Peuter O, Kamphuisen P W. Management strategies for optimal control of anticoagulation in patients with atrial fibrillation. Semin Thromb Hemost. 2009; 35(6) 560-567 9 Levi M. Self-management of anticoagulation. Expert Rev Cardiovasc Ther. 2008; 6(7) 979-985 10 Prisco D, Antonucci E, Grifoni E et al.. Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled—an Italian experience. Semin Thromb Hemost. 2009; 35(6) 568-573 11 Harenberg J. New anticoagulants for the antithrombotic management of atrial fibrillation. Semin Thromb Hemost. 2009; 35(6) 574-586 12 Levi M. New antithrombotics in the treatment of thromboembolic disease. Eur J Intern Med. 2005; 16(4) 230-237
